Delivery Order SPE2DB22D2009-SPE2DB25FM0LJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $30,739.23 under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a $34,557.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-competitive, non-set-aside delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under a larger vehicle, leveraging AmerisourceBergen's established position as a...
- The Defense Logistics Agency awarded a $25,342.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $15,876.35 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed price contract, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $10,858.62. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,111.66 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,359.12 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $19,727.87 and an ultimate completion date of July 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,148.25 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $18,279.31 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract without set-aside designation represents a single delivery order under AmerisourceBergen's larger federal pharmaceutical supply framework. The product will be performed at the contractor's corporate office location in...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0LJDelivery Order
The Defense Logistics Agency awarded a $23,791.28 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit of use packaging), with an ultimate completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's substantial $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's role as a pharmaceutical prime vendor enables the company to supply medications, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The current award reflects the company's established capability to fulfill federal medical procurement requirements and is consistent with its extensive portfolio of delivery orders for brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 7/22/25 |